WLD price reaches $3.989 per coin, up 3.50% on the day
WLD's latest price reached $3.989 today, up as much as 3.50%, with a trading volume of $1.414 billion By looking at the k-chart, it is currently in an oscillating trend. It is more sharply up compared to 14:00, back up from 06:00 and down from 07:00. A simultaneous rise in price and volume usually indicates strong buying support in the market. The willingness of buyers to trade in larger volumes at higher prices suggests an optimistic and bullish market sentiment. In this case, prices are likely to continue to rise in the future as market momentum is strong and buying continues to increase. Investors should keep an eye on the breakout of key resistance levels, as a sustained breakout and firming of the price at a higher position signals a continuation of the uptrend. Overbought condition with active market and strong upward momentum. According to the Williams indicator, it is now overbought. The volume of trading has increased recently, the volume of trading has increased compared to the previous hours, the price and the volume of trading have increased at the same time: trading is active and the upward momentum is strong. The market is optimistic and the uptrend continues, so short-term investors are advised to add to their positions appropriately and pay attention to the breakout of the resistance level. The above is for reference only and does not constitute investment advice.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Variational open interest has exceeded $2 billions.
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.